The National Pharmaceutical Pricing Authority (NPPA) on December 08, 2025, issued the Computation of Retail Price of Paroxetine Hydrochloride Hemihydrate IP Eq. to Paroxetine 12.5 mg (as enteric coated controlled release tablet) + Clonazepam IP 0.25 mg (as uncoated Clonazepam Tablets IP) for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer).
The following has been stated namely: -
• The Retail Price has been computed based on the data from April, 2025
• The Retail Price has been computed for Each Film Coated Tablet Containing Paroxetine Hydrochloride Hemihydrate IP Eq. to Paroxetine 12.5 mg (as enteric coated controlled release tablet) + Clonazepam IP 0.25 mg (as uncoated Clonazepam Tablets IP) for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer).
• The Total MAT is 6,78,39,025
[Notification No. 19(4910)/2025/DP/NPPA/Div.II]
